Pfizer Pharmaceuticals Korea signs co-promotion of ‘Prevenar 13’ with CKD
Pfizer Pharmaceuticals Korea(CEO Dong-Wook Oh) and Chong Kun Dang(CEO Young-Joo Kim, CKD) singed a Korean co-promotion partnership agreement of ‘Prevenar®13’ adult products, a Pfizer Pharmaceuticals Korea’s pneumococcal protein conjugate vaccine, at The Westin Chosun Seoul on the 18th.
The two c...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
